Pfizer’s twice-daily weight loss pill joins a long list of obesity drug flops
Before successful weight loss treatments such as Wegovy and Ozempic, the pharmaceutical path to treating obesity was strewn with failures dating back decades.
Similar Posts
FTX token rallies to $4.85, market cap reaches $1.5 billion
Post Content Post Views: 89
Gen Z, millennials are ‘house hacking’ to become homeowners. How the strategy can help
Gen Zers and millennials are using “house hacking” as a way to secure homeownership in a tough market. Here’s how the strategy works. Post Views: 86
Freddie Mac total mortgage portfolio rises 2.1% in October
Post Content Post Views: 108
How Qatar swayed Israel and Hamas to make a truce work
Post Content Post Views: 88
Dutch politician Wilders’ hopes of building coalition hit hurdle
Post Content Post Views: 81
Warning: AGILQ is at high risk of cutting its dividend
Post Content Post Views: 90